基础医学与临床 ›› 2009, Vol. 29 ›› Issue (5): 479-483.

• 研究论文 • 上一篇    下一篇

脂肪MSCs分泌的DKK-1抑制慢性粒细胞白血病细胞K562的增殖

朱雅姝 孙昭 李振亚 韩钦 李静 赵春华   

  1. 中国医学科学院基础医学研究所组织工程中心 医科院基础医学研究所 中国医学科学院基础医学研究所 中国医学科学院基础医学研究所组织工程中心 中国医学科学院基础医学研究所 中国医学科学院基础医学研究所组织工程中心
  • 收稿日期:2009-01-14 修回日期:2009-02-16 出版日期:2009-05-25 发布日期:2009-05-25
  • 通讯作者: 赵春华

Adipose-derived MSCs inhibit the proliferation of chronic myeloid leukemia cells K562 through secreting DKK-1

Ya-shu ZHU, Zhao SUN, Zhen-ya LI, Qin HAN, Jing LI, Chun-hua ZHAO   

  1. Center for Tissue Engineering, Institute of Basic Medical Science,CAMS & PUMC Center for Tissue Engineering, Institute of Basic Medical Science,CAMS & PUMC Center for Tissue Engineering, Institute of Basic Medical Science,CAMS & PUMC
  • Received:2009-01-14 Revised:2009-02-16 Online:2009-05-25 Published:2009-05-25
  • Contact: Chun-hua ZHAO

摘要: 目的 研究间充质干细胞(MSCs)抑制慢性粒细胞白血病细胞K562增殖的分子机制,为临床治疗提供理论依据。方法 利用脂肪来源的MSCs与慢性粒细胞白血病细胞K562共培养,通过中和抗体实验、3H-TdR 掺入法、细胞周期流式分析、RNA干扰和定量PCR等技术,分析K562细胞增殖能力、WNT信号通路的基因表达变化。 结果 与MSCs共培养后 K562的增殖减少了77%(P<0.05),处于G0/G1期的细胞比例为62.1%±5.8%;而明显高于K562单独培养时的45.2%±6.9%(P<0.05)。当用Transwell隔开MSCs和K562细胞后,上述抑制作用仍然存在。利用中和抗体实验发现MSCs抑制K562增殖是通过分泌DKK-1。将MSCs表达的DKK-1用RNA干扰敲低后,再与K562共培养,可重新增加K562细胞WNT信号通路中β-CATENIN、c-MYC和CYCLIN D2的表达,减弱了对K562增殖的抑制作用。 结论 脂肪来源的MSCs可以通过分泌可溶性分子DKK-1抑制白血病细胞K562的WNT信号通路,将其细胞周期阻滞在G0/G1期,从而抑制其增殖。

关键词: 间充质干细胞, 慢性粒细胞白血病, DKK-1, WNT信号通路, RNA干扰

Abstract: Objective To investigate the molecular mechanism of mesenchymal stem cells' inhibitory effect on the proliferation of chronic myeloid leukemia cells K562. The purpose of this research was to provide the basic and clinical rational for leukemia treatment. Methods Adipose-derived mesenchymal stem cells (MSCs) were co-cultured with K562 cells. Then, the proliferation rate of K562 and the gene expression of WNT signaling pathway in K562 were detected using neutralizing antibodies assays, 3H-TdR assays, cell-cycle assays, RNA interference and real-time PCR assays. Results After co-cultured with MSCs, the proliferation rate of K562 was decreased by 77%(P<0.05), the proportion of K562 cells in G0/G1 phase was significantly higher (62.1%±5.8%) than that (45.2%±6.9%) in K562 cells cultured alone(P<0.05). And MSC's inhibitory effect was not influenced by the transwell system that prevents the direct interaction of MSCs and K562 cells. We performed neutralizing antibodies assays and found that it was DKK-1 that participated this anti-proliferative process. When the expression of DKK-1 was down-regulated by RNA interference, MSCs' inhibitory effects on K562 cells proliferation were attenuated, and the activity of WNT signaling pathway in K562 cells was partially recovered through detecting the accumulation of β-CATENIN and the expression of c-MYC, CYCLIN D2. Conclusions Adipose-derived MSCs could inhibit the leukemia K562 cells' proliferation by secreting DKK-1, which mediated the suppression effects on WNT signaling pathway of K562 cells and resulted in arresting the cell cycle at G0/G1 phase.

Key words: Mesenchymal stem cells, Chronic Myeloid Leukemia, DKK-1, WNT signaling pathway, RNA interference